...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Financials
2
Oct 28, 2020 10:29AM

On page 5 of MD&A it states all tranches were completed, the first three prior to July 31 the last one post July 31. The first three tranches are reflected in the current financials. 

7
Oct 28, 2020 01:20PM
Share
New Message
Please login to post a reply